Sep 08, 2025 11:00
ABP - Abpro Holdings, Inc Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.21 -0.01 (-2.86%) | --- | 0.0 (0.0%) | 0.0 (-0.96%) | -0.03 (-12.15%) | 0.02 (11.61%) | 0.0 (-1.43%) | 0.0 (-1.43%) |
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.08
- Diluted EPS:
- -0.08
- Basic P/E:
- -2.5875
- Diluted P/E:
- -2.5875
- RSI(14) 1m:
- 0.0
- VWAP:
- 0.21
- RVol:
- 0.7838
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 0.2 +0.0 (+1.44%) | Oct 15 09:33 |
| 10m | Price increase 10m | 0.2 +0.01 (+5.86%) | Oct 15 09:32 |
| 1m | Price increase 1m | 0.2 +0.01 (+2.87%) | Oct 15 09:32 |
| 1m | Price increase 1m | 0.19 +0.0 (+2.36%) | Oct 15 09:30 |
| Day | Price decrease day | 0.19 -0.02 (-10.84%) | Oct 15 08:00 |
Related News
Apr 27, 2025 18:00
Mar 10, 2025 22:34